VBI Vaccines (VBI Vaccines) Long-Term Debt : $0.00 Mil (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is VBI Vaccines Long-Term Debt?

VBI Vaccines's Long-Term Debt for the quarter that ended in Dec. 2023 was $0.00 Mil.

VBI Vaccines's quarterly Long-Term Debt declined from Jun. 2023 ($47.84 Mil) to Sep. 2023 ($0.00 Mil) but then stayed the same from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($0.00 Mil).

VBI Vaccines's annual Long-Term Debt increased from Dec. 2021 ($28.44 Mil) to Dec. 2022 ($48.89 Mil) but then declined from Dec. 2022 ($48.89 Mil) to Dec. 2023 ($0.00 Mil).

VBI Vaccines Long-Term Debt Historical Data

The historical data trend for VBI Vaccines's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VBI Vaccines Long-Term Debt Chart

VBI Vaccines Annual Data

Trend

Mar14

Mar15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

16.33

28.44

48.89

VBI Vaccines Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Long-Term Debt	Get a 7-Day Free Trial															48.89	49.36	47.84	-	-

VBI Vaccines (OTCPK:SVACD) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

VBI Vaccines Long-Term Debt Related Terms

Thank you for viewing the detailed overview of VBI Vaccines's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

VBI Vaccines (VBI Vaccines) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VBI Vaccines Inc (OTCPK:SVACD) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

VBIV:USA LO9A:Germany

Address

160 Second Street, Floor 3, Cambridge, MA, USA, 02142

Website

https://www.vbivaccines.com

VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.